title: Differential effects on sensory functions and measures of epidermal nerve fiber density after application of a lidocaine patch (5%) on healthy human skin.
abstract: Topical application of lidocaine is an effective approach for treatment of post-herpetic neuralgia and other painful neuropathies. Lidocaine inhibits voltage-gated Na(+) channels and it most likely reduces excitability of cutaneous sensory neurons which can be hyperexcitable or spontaneously active in states of neuropathic pain. However, lidocaine and other local anesthetics also exert a pronounced neurotoxicity and they activate the irritant receptors TRPV1 and TRPA1. In this randomized and double-blinded study, we explored the ability of lidocaine patches (5%) to alter sensory function and epidermal nerve fiber density in skin of healthy volunteers. As assessed by quantitative sensory testing, significantly elevated thresholds for touch, pin prick pain and mechanically induced wind-up were observed in skin treated with lidocaine patches. These effects reversed to baseline values within 2days after termination of the treatment. Pressure pain and thresholds for heat and cold-induced pain were not affected by the lidocaine patch. A moderate but significant decrease in epidermal nerve fiber density was observed in skin blister roofs obtained after 42days of treatment with lidocaine patches. The placebo patch did not induce any changes in sensory thresholds or nerve fiber density. In conclusion, lidocaine patches seem to have differential effects on sensory modalities in healthy skin. A degeneration of epidermal nerve fibers has previously been demonstrated for patches containing the TRPV1-agonist capsaicin and our findings suggest that this effect might also be relevant for lidocaine patches. These data warrant further studies on molecular mechanisms mediating a relief of neuropathic pain by topical lidocaine.
authors.affiliation: Department of Anesthesiology, University Hospital Erlangen, Krankenhausstrasse 12, 91054 Erlangen, Germany.
authors.forename: Andreas
authors.initials: A
authors.lastname: Wehrfritz
authors.forename: Barbara
authors.initials: B
authors.lastname: Namer
authors.forename: Harald
authors.initials: H
authors.lastname: Ihmsen
authors.forename: Christiane
authors.initials: C
authors.lastname: Mueller
authors.forename: Jörg
authors.initials: J
authors.lastname: Filitz
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Koppert
authors.forename: Andreas
authors.initials: A
authors.lastname: Leffler
mesh_terms: D000279:Administration, Cutaneous; D000293:Adolescent; D000328:Adult; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000494:pharmacology*; D004311:Double-Blind Method; D004817:Epidermis / Q000187:drug effects* / Q000294:innervation; D006801:Humans; D008012:Lidocaine / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D009412:Nerve Fibers / Q000187:drug effects*; D010147:Pain Measurement / Q000187:drug effects; D058748:Pain Perception / Q000187:drug effects*; D012684:Sensory Thresholds / Q000187:drug effects; D055698:Touch Perception / Q000187:drug effects*; D057968:Transdermal Patch
chemical_list: D000779:Anesthetics, Local; D008012:Lidocaine